Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
J Neurochem. 2019 Mar;148(5):639-651. doi: 10.1111/jnc.14632. Epub 2018 Dec 13.
Mucopolysaccharidoses are lysosomal storage disorders characterised by accumulation of abnormal pathological glycosaminoglycans, cellular dysfunction and widespread inflammation, resulting in progressive cognitive and motor decline. Lysosomes are important mediators of immune cell function, and therefore accumulation of glycosaminoglycans (GAGs) and other abnormal substrates could affect immune function and directly impact on disease pathogenesis. This review summarises current knowledge with regard to inflammation in mucopolysaccharidosis, with an emphasis on the brain and outlines a potential role for GAGs in induction of inflammation. We propose a model by which the accumulation of GAGs and other factors may impact on innate immune signalling with particular focus on the Toll-like receptor 4 pathway. Innate immunity appears to have a dominating role in mucopolysaccharidosis; however, furthering understanding of innate immune signalling would have significant impact on highlighting novel anti-inflammatory therapeutics for use in mucopolysaccharide diseases. This article is part of the Special Issue "Lysosomal Storage Disorders".
黏多糖贮积症是一种溶酶体贮积病,其特征是异常病理糖胺聚糖的积累、细胞功能障碍和广泛的炎症,导致进行性认知和运动能力下降。溶酶体是免疫细胞功能的重要介质,因此糖胺聚糖(GAG)和其他异常底物的积累可能会影响免疫功能,并直接影响疾病的发病机制。这篇综述总结了黏多糖贮积症中炎症的现有知识,重点介绍了大脑,并概述了 GAG 在炎症诱导中的潜在作用。我们提出了一个模型,即 GAG 和其他因素的积累可能会影响先天免疫信号转导,特别关注 Toll 样受体 4 途径。先天免疫似乎在黏多糖贮积症中起着主导作用;然而,进一步了解先天免疫信号转导将对突出用于黏多糖疾病的新型抗炎治疗具有重要意义。本文是“溶酶体贮积症”特刊的一部分。